代谢手术前肌肉质量与术后1年糖尿病缓解:不同缓解定义的关联
这项回顾性队列研究纳入70例接受胃旁路术或袖状胃切除术的2型糖尿病患者,评估术前因素与术后1年不同定义糖尿病缓解的关联。共识定义缓解率为80.0%,严格生化正常血糖达标率为34.3%。术前肌肉质量与共识定义缓解无关,但与严格生化正常血糖达标独立相关。
要点
- 共识定义缓解率达80.0%,严格生化正常血糖达标率为34.3%。
- 糖尿病病程短与两种缓解定义均独立相关。
- 术前肌肉质量仅与严格生化正常血糖达标相关,加入ABCD和IMS评分可改善区分度。
核心结论
- 术前肌肉质量与共识定义的糖尿病缓解无关,但与代谢手术后的严格生化正常血糖达标独立相关。
- 在ABCD和IMS评分中加入绝对总肌肉质量或残差化肌肉质量可改善对严格生化正常血糖达标的交叉验证区分度,但该发现仍属探索性,需外部验证。
研究设计与样本
- 回顾性队列研究,纳入70例术前BMI≥27.5 kg/m²并接受Roux-en-Y胃旁路术或袖状胃切除术的2型糖尿病患者。
- 主要结局为最接近12个月评估时点的共识定义糖尿病缓解,即停用所有降糖药至少3个月后HbA1c<6.5%。
- 次要结局为严格生化正常血糖(stringent biochemical normoglycaemia)和术后三个评估时点均达到缓解。
主要发现
- 70例患者中56例(80.0%)达到共识定义缓解,24例(34.3%)达到严格生化正常血糖达标。
- 糖尿病病程短与共识定义缓解独立相关(校正后OR为0.24,95%CI 0.06–0.65),绝对总肌肉质量与之无关(校正后OR为1.24,95%CI 0.54–2.97)。
- 对于严格生化正常血糖达标,糖尿病病程短、空腹C肽较高和绝对总肌肉质量较大与该结局独立相关。
- 探索性敏感性分析中,残差化肌肉质量也与严格生化正常血糖达标相关。
关键数值与推荐
- 共识定义糖尿病缓解:HbA1c<6.5%,在停用所有降糖药物至少3个月后测量。
- 术前BMI纳入标准:≥27.5 kg/m²。
- 共识定义缓解的糖尿病病程校正后OR为0.24(95%CI 0.06–0.65)。
- 共识定义缓解的绝对总肌肉质量校正后OR为1.24(95%CI 0.54–2.97)。
临床怎么用
- 在评估代谢手术后严格血糖正常化可能性时,可考虑将术前肌肉质量测量纳入现有预测评分。
- 糖尿病病程较短的患者术后获得缓解的可能性更高,可用于术前咨询。
局限性
- 样本量为70例,结果可能受限于统计效能。
- 肌肉质量相关发现为探索性,需外部验证。
- 回顾性设计存在选择偏倚和混杂因素控制局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Aims This study aimed to evaluate 1-year T2DM remission and preoperative factors associated with remission across different outcome definitions following metabolic surgery. Methods This retrospective cohort study included patients with T2DM and a preoperative BMI ≥ 27.5 kg/m2 who underwent Roux-en-Y gastric bypass or sleeve gastrectomy. The primary outcome was consensus-defined diabetes remission at the assessment closest to 12 months, defined as HbA1c < 6.5% measured ≥ 3 months after discontinuation of all glucose-lowering medications. Secondary outcomes were stringent biochemical normoglycaemia and remission at all three postoperative assessments. Results Among 70 patients, 56 (80.0%) achieved consensus-defined remission and 24 (34.3%) achieved stringent biochemical normoglycaemia at 1 year. Shorter diabetes duration was independently associated with consensus-defined remission (adjusted OR [aOR], 0.24; 95% CI: 0.06–0.65), whereas absolute total muscle mass (TMM) was not (aOR, 1.24; 95% CI: 0.54–2.97). For stringent biochemical normoglycaemia, shorter diabetes duration, higher fasting C-peptide and greater absolute TMM were independently associated with the outcome. Residualized muscle mass (RMM) was also associated with this outcome in exploratory sensitivity analyses. Adding muscle measures to the ABCD and IMS scores improved cross-validated discrimination for this stringent outcome. Conclusions Preoperative muscle mass was not associated with consensus-defined diabetes remission but was associated with stringent biochemical normoglycaemia after metabolic surgery. Adding either absolute TMM or RMM to established remission scores improved cross-validated discrimination for this stringent outcome; however, these findings remain exploratory and require external validation.
引用
- Diabetes, Obesity and Metabolism:Preoperative Muscle Mass and 1‐Year Diabetes Remission After Metabolic Surgery: Associations Across Remission Definitions
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。